Short Schedule of Cisplatin and Vinorelbine: A Dose-Finding Study in Non-Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0232|71|3-4|229-236

ISSN： 0030-2414

Source： Oncology, Vol.71, Iss.3-4, 2007-07, pp. : 229-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vinorelbine and Alternating Cisplatin and Ifosfamide in the Treatment of Non-Small Cell Lung Cancer

By  

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 25-30

Karger

Access to resources Recommend Favorite

Oral Vinorelbine and Cisplatin with Concomitant Radiotherapy in Stage III Non-Small Cell Lung Cancer (NSCLC): A Feasibility Study

By  

Oncology Research and Treatment, Vol. 29, Iss. 4, 2006-03 ,pp. : 137-142

Karger

Access to resources Recommend Favorite

Is Cisplatin Required for the Treatment of Non-Small-Cell Lung Cancer? Experience and Preliminary Results of a Phase I/II Trial with Topotecan and Vinorelbine

By  

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 35-41

Karger

Access to resources Recommend Favorite

A 53-Year-Old Patient with Unilateral Pulmonary Infiltrates following a Single Dose of Mitomycin, Vindesine and Cisplatin Chemotherapy for Non-Small-Cell Lung Cancer

By  

Respiration, Vol. 66, Iss. 6, 1999-11 ,pp. : 562-572

Karger

Access to resources Recommend Favorite

Pharmacokinetic Study of Weekly (Days 1-5) Low-dose S-1 in Patients with Non-Small-Cell Lung Cancer

By  

Reviews on Recent Clinical Trials, Vol. 7, Iss. 2, 2012-05 ,pp. : 167-172

Bentham Science Publishers

Access to resources Recommend Favorite